ArticleMedical sciences (Basel, Switzerland)2026
Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients.
Aimilios Kaklamanos, Vasileios Serepisios, Sofia Chelioti, Kalliopi Zervakou, George Christodoulou, Abraham Pouliakis, Konstantina Mikelopoulou, Daphnie Germanou, Ilias Tsinokou, Dimitrios Dorotheos Papadakis and 2 more
Abstract readComparative Study
In one paragraphArticle in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Aimilios KaklamanosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vasileios SerepisiosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0002-9894-1142 Sofia CheliotiDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0004-3094-3162 Kalliopi ZervakouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
George ChristodoulouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abraham Pouliakis2nd Department of Pathology, University Hospital "Attikon", National and Kapodistrian University of Athens, 12461 Athens, Greece.ORCID 0000-0002-0074-3619 Konstantina MikelopoulouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Daphnie GermanouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0000-7731-126X Ilias TsinokouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Dimitrios Dorotheos PapadakisDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-4422-1262 Christos TsironisDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Theodoros AndroutsakosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2556-6230 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
EnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightThrombosisAgedAged, 80 and overAnticoagulantsDose-Response Relationship, DrugFemaleHemorrhageHospitalizationHumansInternal MedicineMaleMiddle AgedTinzaparinAnticoagulantsEnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightTinzaparinbleedingenoxaparinthrombosis prophylaxistinzaparin
Identifiers
PMID42646559
PMCPMC13515995
What OpenQuestion holds
Textmetadata
Read underepoch 390